CAC
SRNE

Cowen and Company’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cowen and Company’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-129,200
Closed -$1.44M – 371
2020
Q3 		$1.44M Buy
+129,200
New +$1.44M 0.24% 62